Review: taking Warfarin sodium and Lisinopril together


Summary

Drug interactions are reported among people who take Warfarin sodium and Lisinopril together. This review analyzes the effectiveness and drug interactions between Warfarin sodium and Lisinopril. It is created by eHealthMe based on reports of 15,200 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Warfarin Sodium

Warfarin sodium has active ingredients of warfarin sodium. It is often used in atrial fibrillation/flutter. (latest outcomes from Warfarin sodium 53,624 users)

Lisinopril

Lisinopril has active ingredients of lisinopril. It is often used in high blood pressure. (latest outcomes from Lisinopril 164,525 users)

On Sep, 16, 2016

15,200 people who take Warfarin Sodium, Lisinopril are studied.


Number of reports submitted per year:

Warfarin sodium and Lisinopril drug interactions.

Drug effectiveness over time:

Warfarin Sodium:
  • < 1 month: 15.0% - (2 of 13 people)
  • 1 - 6 months: 51.0% - (15 of 29 people)
  • 6 - 12 months: 55.0% - (10 of 18 people)
  • 1 - 2 years: 62.0% - (22 of 35 people)
  • 2 - 5 years: 52.0% - (24 of 46 people)
  • 5 - 10 years: 89.0% - (25 of 28 people)
  • 10+ years: 82.0% - (19 of 23 people)
  • not specified: 100.0% - (1 of 1 people)
Lisinopril:
  • < 1 month: 0.0% - (0 of 10 people)
  • 1 - 6 months: 30.0% - (7 of 23 people)
  • 6 - 12 months: 46.0% - (7 of 15 people)
  • 1 - 2 years: 40.0% - (11 of 27 people)
  • 2 - 5 years: 48.0% - (27 of 56 people)
  • 5 - 10 years: 74.0% - (26 of 35 people)
  • 10+ years: 44.0% - (11 of 25 people)
  • not specified: 0.0% - (0 of 1 people)

Drug effectiveness by gender:

Warfarin Sodium:
  • female: 51.0% - (39 of 76 people)
  • male: 67.0% - (79 of 117 people)
Lisinopril:
  • female: 37.0% - (28 of 74 people)
  • male: 51.0% - (61 of 118 people)

Drug effectiveness by age:

Warfarin Sodium:
  • 0-1: 100.0% - (1 of 1 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 100.0% - (1 of 1 people)
  • 30-39: 33.0% - (2 of 6 people)
  • 40-49: 57.0% - (12 of 21 people)
  • 50-59: 58.0% - (27 of 46 people)
  • 60+: 63.0% - (75 of 118 people)
Lisinopril:
  • 0-1: 100.0% - (1 of 1 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 57.0% - (4 of 7 people)
  • 40-49: 52.0% - (11 of 21 people)
  • 50-59: 43.0% - (20 of 46 people)
  • 60+: 45.0% - (53 of 116 people)

Most common drug interactions over time *:

< 1 month:
  • international normalised ratio increased
  • gastrointestinal haemorrhage
  • pneumonia
  • skin ulcer
  • anaemia
  • dyspnoea
  • impaired healing
  • hypotension
  • renal failure acute
  • gastric ulcer
1 - 6 months:
  • international normalised ratio increased
  • gastrointestinal haemorrhage
  • fatigue
  • proteinuria
  • dyspnoea
  • headache
  • asthenia
  • cardiac failure
  • myocardial ischaemia
  • rectal haemorrhage
6 - 12 months:
  • gastrointestinal haemorrhage
  • international normalised ratio increased
  • fatigue
  • anaemia
  • cerebrovascular accident
  • skin ulcer
  • dehydration
  • diarrhoea
  • dyspnoea
  • fall
1 - 2 years:
  • depression
  • hypertension
  • international normalised ratio increased
  • anxiety
  • fatigue
  • cardiac failure congestive
  • congestive cardiomyopathy
  • nightmare
  • asthenia
  • dizziness
2 - 5 years:
  • anxiety
  • depression
  • impaired healing
  • dysphonia
  • cerebrovascular accident
  • infection
  • loose tooth
  • osteonecrosis
  • pain
  • angioedema
5 - 10 years:
  • fatigue
  • dizziness
  • oedema peripheral
  • asthenia
  • hypotension
  • lip swelling
  • oedema genital
  • decreased appetite
  • depression
  • malaise
10+ years:
  • international normalised ratio increased
  • renal failure acute
  • mental status changes
  • bradycardia
  • dizziness
  • atrial fibrillation
  • cardiac failure congestive
  • chest pain
  • gingival bleeding
  • haemoglobin decreased
not specified:
  • pain
  • dyspnoea
  • cardiac failure congestive
  • atrial fibrillation
  • nausea
  • anxiety
  • fatigue
  • dizziness
  • international normalised ratio increased
  • asthenia

Most common drug interactions by gender *:

female:
  • pain
  • dyspnoea
  • nausea
  • atrial fibrillation
  • cardiac failure congestive
  • anxiety
  • fatigue
  • diarrhoea
  • fall
  • asthenia
male:
  • pain
  • dyspnoea
  • cardiac failure congestive
  • atrial fibrillation
  • international normalised ratio increased
  • fatigue
  • nausea
  • dizziness
  • anxiety
  • asthenia

Most common drug interactions by age *:

0-1:
  • muscular weakness
  • tremor
  • cerebrovascular accident
  • endocarditis
  • heart racing
  • neoplasm malignant
  • prothrombin level increased
  • rash
  • reaction to azo-dyes
  • tolerance increased
2-9:
  • international normalised ratio increased
  • mouth haemorrhage
  • ageusia
  • anosmia
  • convulsion
  • haemorrhage
  • haemorrhage subcutaneous
  • petechiae
  • purpura
  • rash macular
10-19:
  • nausea
  • vomiting
  • cardiac failure congestive
  • dyspnoea
  • tachycardia
  • atrial fibrillation
  • haematuria
  • fatigue
  • pulmonary embolism
  • decreased appetite
20-29:
  • cardiac failure congestive
  • back pain
  • bronchitis
  • atrial fibrillation
  • injury
  • urinary tract infection
  • dyspnoea
  • influenza like illness
  • nausea
  • cardiomegaly
30-39:
  • nausea
  • vomiting
  • anxiety
  • pain
  • pulmonary embolism
  • hypoaesthesia
  • dyspnoea
  • headache
  • abdominal pain
  • deep vein thrombosis
40-49:
  • pain
  • cardiac failure congestive
  • nausea
  • atrial fibrillation
  • dyspnoea
  • fatigue
  • international normalised ratio increased
  • anxiety
  • hypotension
  • dizziness
50-59:
  • pain
  • anxiety
  • cardiac failure congestive
  • dyspnoea
  • oedema peripheral
  • fatigue
  • nausea
  • atrial fibrillation
  • depression
  • injury
60+:
  • dyspnoea
  • atrial fibrillation
  • pain
  • cardiac failure congestive
  • international normalised ratio increased
  • nausea
  • fatigue
  • asthenia
  • dizziness
  • anaemia

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Warfarin sodium and Lisinopril?

Can you answer these questions?

More questions for: Warfarin sodium, Lisinopril

You may be interested in these reviews

More reviews for: Warfarin sodium, Lisinopril

On eHealthMe, Warfarin sodium (warfarin sodium) is often used to treat atrial fibrillation/flutter. Lisinopril (lisinopril) is often used to treat high blood pressure. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.